The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without diabetes.
source https://www.sciencedaily.com/releases/2024/11/241125195050.htm
Qualcomm, Nvidia ready for 'AI-native' 6G, if only the world knew what it
was
-
Meanwhile, formal 6G specs are still in the works
It seems like just yesterday that the 5G rollout started. Now, at Mobile
World Congress, major companies...
6 hours ago
Welcome to the 'The Fact Factory' friends. Its an interesting Hot Spot which brings to you amazing and little known facts from all over the world. So, sit back, take a tour around the world and enjoy the trivia.
No comments:
Post a Comment